Yu Dong

Phase 1b Study of Sintilimab Plus Anlotinib as First-line Therapy in Patients With Advanced NSCLC

Tianqing Chu, Runbo Zhong, Hua Zhong et al. · Journal of Thoracic Oncology · 2021 · 226 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +4

Combination of chemotherapy and gefitinib as first-line treatment for patients with advanced lung adenocarcinoma and sensitive EGFR mutations: A randomized controlled trial

Baohui Han, Bo Jin, Tianqing Chu et al. · International Journal of Cancer · 2017 · 153 citations · Full text

Medicine, Oncology, Pharmacology +12

Lactate modulates RNA splicing to promote CTLA-4 expression in tumor-infiltrating regulatory T cells

Rui Ding, Xiaoyan Yu, Zhilin Hu et al. · Immunity · 2024 · 121 citations · Full text

Life Sciences, Molecular Biology, Oncology +16

Effects of low-level laser therapy on ROS homeostasis and expression of IGF-1 and TGF-β1 in skeletal muscle during the repair process

Li Luo, Zhongwen Sun, Lin Zhang et al. · Lasers in Medical Science · 2012 · 78 citations

Natural Sciences, Biophysics, Endocrinology +15

Dcaf11 activates Zscan4-mediated alternative telomere lengthening in early embryos and embryonic stem cells

Rongrong Le, Yixin Huang, Yanping Zhang et al. · Cell stem cell · 2020 · 72 citations · Full text

Life Sciences, Developmental Biology, Genetics +15